In 2022, Italy spent over €1 billion on medicines deemed potentially harmful by Prescrire International, which identified 115 drugs to avoid. The analysis revealed that 15 medicines accounted for 75% of this spending. While the Italian Medicines Agency (AIFA) did not comment on the findings, experts suggest that eliminating these drugs may not significantly reduce costs, as patients may switch to more expensive alternatives. Teljes cikk (Euronews.com)